Skip to main navigation Skip to search Skip to main content

High-risk fludarabine-pretreated B-cell chronic lymphocytic leukemia's high response rate following sequential DHAP and alemtuzumab administration though in absence of molecular remission

  • Ignazio Majolino
  • , Marco Ladetto
  • , Anna Locasciulli
  • , Daniela Drandi
  • , Fabio Benedetti
  • , Andrea Gallamini
  • , Teodoro Chisesi
  • , Angelo De Blasio
  • , Mario Boccadoro
  • , Corrado Tarella

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'High-risk fludarabine-pretreated B-cell chronic lymphocytic leukemia's high response rate following sequential DHAP and alemtuzumab administration though in absence of molecular remission'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology